NCT05344365View on ClinicalTrials.gov

A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Parkinson Disease Psychosis
Interventions
DRUG

Iloperidone

oral tablet

Trial Locations (1)

33713

Vanda Investigational Site, St. Petersburg

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY